IP Library Patent Application 11592699
Patent Application
App. No. 11/592,699

Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/592,699
Abstract

Methods are disclosed for predicting the efficacy of a drug for treating an inflammatory disease in a human patient, including: obtaining a sample of cells from the patient; obtaining a gene expression profile of the sample in the absence and presence of in vitro modulation of the cells with specific cytokines and/or mediators; and comparing the gene expression profile of the sample with a reference gene expression profile, wherein similarities between the sample expression profile and the reference expression profile predicts the efficacy of the drug for treating the inflammatory disease in the patient.

Claims (4)

1 . An expression profile comprising expression levels of gene products from one or more genes described in Tables 1, 2A, 2B, 4A, 4B and 5A-5E.

2 . The expression profile of claim 1 , wherein the expression profile comprises about 5 informative genes.

3 . The expression profile of claim 1 , wherein the expression profile comprises about 5 to about 100 informative genes.

4 . The expression profile of claim 1 , wherein the informative genes exhibit the greatest degree of differential expression between responders and non-responders.

Assignments (1)
GRANT OF PATENT SECURITY INTEREST Recorded Nov 12, 2009
From: DECODE GENETICS EHF (IN ICELANDIC: ISLENSK ERFDAGREINING EHF)
To: SAGA INVESTMENTS LLC
Reel/Frame 023510/0243 →